Similar articles

• Contribution of the metabolite 7-hydroxy-delta1-tetrahydrocannabinol towards the pharmacological activity of delta 1-tetrahydrocannabinol in mice.

  Gill EW, Jones G, Lawrence DK. Gill EW, et al. Biochem Pharmacol. 1973 Jan 15;22(2):175-84. doi: 10.1016/0006-2952(73)90271-2. Biochem Pharmacol. 1973. PMID: 4763251 No abstract available.
• The distribution of delta1-tetrahydrocannabinol and 7-hydroxy-delta-tetrahydrocannabinol in the mouse brain after intraventricular injection.

  Gill EW, Lawrence DK. Gill EW, et al. J Pharm Pharmacol. 1973 Dec;25(12):948-52. doi: 10.1111/j.2042-7158.1973.tb09984.x. J Pharm Pharmacol. 1973. PMID: 4150297 No abstract available.
• Brain levels and relative potency of the 1,2-dimethylheptyl analogue of delta1-tetrahydrocannabinol in mice.

  Lawrence DK, Pertwee RG, Gill EW, Piper JM. Lawrence DK, et al. Biochem Pharmacol. 1974 Nov 1;23(21):3017-27. doi: 10.1016/0006-2952(74)90277-9. Biochem Pharmacol. 1974. PMID: 4429599 No abstract available.
• The physiologic disposition of marihuana in man.

  Lemberger L, Rubin A. Lemberger L, et al. Life Sci. 1975 Dec 1;17(11):1637-42. doi: 10.1016/0024-3205(75)90108-3. Life Sci. 1975. PMID: 1107735 Review. No abstract available.
• The metabolism of the tetrahydrocannabinols.

  Lemberger L. Lemberger L. Adv Pharmacol Chemother. 1972;10:221-55. doi: 10.1016/s1054-3589(08)60525-6. Adv Pharmacol Chemother. 1972. PMID: 4598605 Review. No abstract available.